Poor and unusually prolonged oral absorption of amphotericin B in rats

Pharmaceutical Research

Volumn 16, Issue 3, 1999, Pages 455-458

  Robbie, Gabriel ^a   Wu, Ta Chen ^b   Chiou, Win L ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NONE

Author keywords

Amphotericin B; GI permeability; Intestinal absorption; Mean absorption time; Mean hepatic transit time

Indexed keywords

AMPHOTERICIN B;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG PENETRATION; GASTROINTESTINAL ABSORPTION; INTESTINE MUCOSA PERMEABILITY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ABSORPTION; ADMINISTRATION, ORAL; AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; INTESTINAL ABSORPTION; LIVER; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032929618     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1011961322883     Document Type: Article

References (18)

1. 1. H. A. Gallis, R. H. Drew, and W. W. Pickard. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-329 (1990).
2. 2. M. S. Ching, K. Raymond, R. W. Bury, M. L. Mashford, and D. J. Morgan. Absorption of orally administered amphotericin B lozenges. Br. J. Clin. Pharmac. 16:106-108 (1983).
3. 3. Gabriel Robbie. Amphotericin B: Oral Absorption in Rats and Elucidation of Human Pharmacokinetics and Interspecies Scaling. Ph. D. Thesis, University of Illinois at Chicago (1998).
4. 4. M. G. Lee and W. L. Chiou. Potential causes for incomplete bioavailability of furosemide. J. Pharmacokin. Biopharm. 11:623-640 (1983).
5. 5. F. H. Hsu, T. Prueksaritanont, M. G. Lee, and W. L. Chiou. The phenomenon and cause of the dose-dependent oral absorption of chlorothiazide in rats: extrapolation to human data based on the body surface area concept. J. Pharmacokin. Biopharm. 15:369-386 (1987).
6. 6. S. H. Lee, M. G. Lee, and N. D. Kim. Pharmacokinetics and pharmacodynamics of bumetanide after intravenous and oral administration to rats: absorption from various GI segments. J. Pharmacokin. Biopharm. 22:1-17 (1994).
7. 7. M. H. AbdelHameed, T. M. Chen, and W. L. Chiou. Intrahepatic distribution of hydrochlorothiazide and quinidine in rats: implications in pharmacokinetics. J. Pharm. Sci. 82:992-996 (1993).
8. 8. C. L. Golas, C. G. Prober, S. M. MacLeod, and S. J. Soldin. Measurement of amphotericin B in serum or plasma by high-performance liquid chromatography. J. Chromatogr. 278:387-395, (1983).
9. 9. G. Robbie and W. L. Chiou. Elucidation of human amphotericin B pharmacokinetics: Identification of new potential factor affecting pharmacokinetic interspecies scaling. Pharm. Res. (in press).
10. 10. M. Gibaldi and D. Perrier. Pharmacokinetics, 2nd ed., Marcel Dekker, Inc. New York and Basel (1982).
11. 11. W. L. Chiou. Mean hepatic transit time in the determination of mean absorption time. J. Pharm. Sci. 72:1365-1368 (1983).
12. 12. A. Bernareggi and M. Rowland. Physiologic modeling of cyclosporine kinetics in rat and man. J. Pharmacokin. Biopharm. 19:21-50 (1991).
13. 13. W. R. Chappell and J. Mordenti. Extrapolation of toxicological and pharmacological data from animals to humans. Advances in Drug Research 20:1-115 (1991).
14. 14. H. Yuasa, W. Numata, S. Ozeki, and J. Watanabe. Effect of dosing volume on gastrointestinal absorption in rats: Analysis of the gastrointestinal disposition of L-glucose and estimation of in vivo intestinal membrane permeability. J. Pharm. Sci. 84:476-481 (1995).
15. 15. H. Tsubaki and T. Komai. Intestinal absorption of choline in rats. J. Pharmacobio-Dyn. 10:571-579 (1987).
16. 16. C. G. Adair and J. C. McElnay. Studies on the mechanism of gastrointestinal absorption of melphalan and chloroambucil. Cancer Chemother. Pharmacol. 17:95-98 (1986).
17. 17. R. L. Perry, C. B. Carrig, J. F. Williams, C. A. Johson, and J. B. Kaneene. Anatomic features and radiographic observations of gastric emptying and small intestinal motility in the rat. Lab. Anim. Sci. 43:586-593 (1993).
18. 18. W. L. Chiou and A. Barve. Linear correlation of the fraction of oral dose absorbed of 64 drugs between humans and rats. Pharm. Res. 15:1792-1795 (1998).